Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-01-31 to 2024-02-01
Current total value of award: $1089.45
Description: 4563501569!QUILLIVANT XR ORAL SUSP 180ML 5MG/ML